• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMÉRIEUX, SA API® 20 A 25STRIPS+25MEDIA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMÉRIEUX, SA API® 20 A 25STRIPS+25MEDIA Back to Search Results
Model Number 20300
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Event Description
A customer in the united states notified biomérieux of obtaining a misidentification result in association with the api® 20 a (ref.20300, lot 1008247410) when testing a cap survey strain.The customer stated lot 1008247410 identified the isolate as prevotella bivia, and confirmed the expected result for the survey strain was prevotella melaninogenica.The customer repeated testing and the same misidentification result was obtained.Biomérieux customer service has requested the cap survey strain as well as customer methodology and troubleshooting information.As there is no patient associated with this survey strain, there is no adverse event related to any patient's state of health.Biomerieux has initiated an internal investigation.
 
Manufacturer Narrative
A customer in the united states notified biomérieux of obtaining a misidentification result in association with the api® 20 a (ref.(b)(4), lot 1008247410) when testing a cap survey strain.Investigation: review of the complaints database revealed no other complaints related to the same issue with the customer¿s lot number.Testing: a retained sample from the impacted lot number (1008247410) was tested in parallel with one internal lot number used as reference (1008024290).The tests used the qc strains bacteroïdes ovatus atcc® 8483¿, clostridium perfringens atcc® 13124¿ and clostridium sordellii atcc® 9714¿ mentioned in the package insert 07882 version i.The qc results obtained for the three strains tested are in accordance with the expected specifications.The identification of the strain received was confirmed in-house with vitek ms as prevotella melaninogenica.In the api 20 a knowledge base, only three tests discriminate between prevotella melaninogenica and prevotella bivia.The concerned tests are sac, raf and gly.Negative results for sac and raf tests were obtained and the investigation reproduced the same results for these two tests.Positive results for gly test were obtained and the investigation obtained a doubtful result (¿?¿).The following are mentioned in the api 20 a knowledge base : sac test: 0% for prevotella bivia and 83% for prevotella melaninogenica; raf test: 0% for prevotella bivia and 89% for prevotella melaninogenica; gly test: 80% for prevotella bivia and 18% for prevotella melaninogenica.The results obtained during the investigation on those three tests are more in accordance with prevotella bivia.Such results can nevertheless be observed for some prevotella melaninogenica strains but they remain in the minority of this species.The results of quality control obtained during our investigation on the impacted product api® 20 a, reference (b)(4), lot 1008247410 complied with specifications.The batch records analysis does not show any non-conformities during manufacturing and quality control processes (lot #1008247410).The trend analysis of the complaints does not show any deviation on the product api® 20 a, reference (b)(4).Conclusion: the root cause of this customer¿s issue is the atypical results obtained using the cap survey strain; negative results for two (2) discriminant tests, sac and raf, instead of positive results and positive result for discriminant test gly instead of negative result.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
API® 20 A 25STRIPS+25MEDIA
Type of Device
API® 20 A 25STRIPS+25MEDIA
Manufacturer (Section D)
BIOMÉRIEUX, SA
3 route de port michaud
la balme 38390
FR  38390
Manufacturer (Section G)
BIOMÉRIEUX, SA
3 route de port michaud
la balme 38390
FR   38390
Manufacturer Contact
jeff scanlan
595 anglum road
hazelwood, MO 63042
MDR Report Key11873537
MDR Text Key252366737
Report Number9615754-2021-00168
Device Sequence Number1
Product Code JSP
UDI-Device Identifier03573026048150
UDI-Public03573026048150
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
C1 EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 11/22/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/24/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/20/2021
Device Model Number20300
Device Catalogue Number20300
Device Lot Number1008247410
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/27/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/19/2020
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage A
Patient Sequence Number1
-
-